Queensland: Your biomedical launch-pad to the Asia-Pacific

Queensland is a preferred destination for investors seeking strategic biomedical partnerships – combining world-class research, clinical excellence and growing manufacturing capability with direct access to high-growth Asia-Pacific markets.

The Queensland Government is open for business. Through our Team Queensland approach, we work in partnership with industry to accelerate growth through strategic investment, coordinated engagement, and strong collaboration across government, academia and industry.

Why Queensland

Queensland offers a compelling value proposition for global pharmaceutical, biotechnology and medical technology companies:

• Gateway to Asia-Pacific – aligned time zones, established trade links and seamless access to fast-growing markets
• Strategic government investment – supporting industry development and partnership opportunities
• Globally connected clinical trials network – delivering high-quality trials across all phases with data accepted worldwide
• Advanced healthcare system – integrated electronic Medical Record (ieMR) enabling world-class clinical care and research at scale
• Competitive R&D incentives – including up to 43.5% R&D tax incentive for eligible companies
• Highly skilled workforce – supported by a strong foundational research base and leading institutions
• Pro-business environment – stable, innovation-focused and globally connected

End-to-end biomedical capability

Queensland provides the expertise and infrastructure to support biomedical development from discovery through to commercialisation:

• Strong foundational research base with state-of-the-art infrastructure and deep technical expertise
• Capability in vaccines, biologics, RNA and personalised medicines
• Expanding biomanufacturing capacity, including ENTRI – Australia’s first on-demand cGMP manufacturing facility (opening 2026)
• Globally connected clinical trial network

A destination of choice for global leaders

Leading international companies are investing in Queensland’s biomedical ecosystem. Global organisations including Stryker and Sanofi have established a strong R&D presence, recognising Queensland’s capability to support innovation and growth.

Queensland’s proven collaborative model, linking hospitals, research institutes and industry, continues to attract multinational partners seeking efficient pathways to market.

Partner with Queensland

Queensland is seeking partnerships with global biomedical companies looking to:

• Establish or expand facilities and R&D operations
• Undertake high-quality clinical trials
• Build biomanufacturing capability
• Access and grow in Asia-Pacific markets

As Queensland prepares to welcome the world for the 2032 Olympic and Paralympic Games, it’s time for international investors to put themselves in a win–win position and choose Queensland as their preferred location.